Savara Announces Pricing of $130.0 Million Public Offering of Common Stock and Pre-funded Warrants

Core Viewpoint - Savara Inc. has announced the pricing of a public offering of common stock and pre-funded warrants, indicating a strategic move to raise capital for its operations focused on rare respiratory diseases [1] Group 1: Offering Details - The company is offering 23,809,524 shares of its common stock at a price of $4.20 per share [1] - Additionally, the offering includes pre-funded warrants to purchase 7,142,857 shares of common stock at a price of $4.199 per warrant [1] - The pricing is set before deducting underwriting discounts and commissions, highlighting the financial structure of the offering [1]